z-logo
open-access-imgOpen Access
Reasoned opinion on the modification of the existing MRLs for tebuconazole in citrus (except oranges), lettuce and other salad plants, parsley and chives
Publication year - 2012
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2012.2898
Subject(s) - tebuconazole , horticulture , biology , traditional medicine , botany , fungicide , medicine
In accordance with Article 6 of Regulation (EC) No 396/2005, Spain received an application from Makhteshim Agan Espana, S.A. to modify the existing MRLs for the active substance tebuconazole in citrus fruit (except oranges). Spain also received an application from Bayer CropScience to modify the existing MRL for tebuconazole for lettuce and other salad plants including Brassicaceae. Germany received an application from the plant protection service LSA (Landesanstalt für Landwirtschaft, Forsten und Gartenbau Sachsen‐Anhalt) to modify the MRLs for tebuconazole on parsley and chives. Spain and Germany drafted the evaluation reports in accordance with Article 8 of Regulation (EC) No 396/2005, which were submitted to the European Commission and forwarded to EFSA. For reasons of efficiency EFSA combined the three applications in one reasoned opinion. According to EFSA the data are sufficient to derive MRL proposals for the crops under consideration. Adequate analytical enforcement methods are available to control residues of tebuconazole on the commodities for which a MRL is proposed at the validated LOQ of 0.02 mg/kg. Based on the risk assessment results, EFSA concludes that the proposed uses of tebuconazole on citrus fruit (except oranges), lettuce and other salad plants including Brassicaceae, chives and parsley will not result in a consumer exposure exceeding the toxicological reference values and therefore are unlikely to pose a consumer health risk.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here